Boston-based Dana-Farber Cancer Institute ended 2017 with an operating loss of $36.8 million, compared to operating income of $29.7 million in the year prior.
Dana-Farber saw revenues increase 8.4 percent year over year to $1.52 billion in 2017, according to recently released bondholder documents. The hospital's patient service revenue and research revenue grew 6 percent and 12.3 percent, respectively, year over year.
Higher expenses offset the hospital's revenue gains. In 2017, Dana-Farber recorded operating expenses of $1.56 billion. That's up from $1.38 billion in the year prior.
After factoring in strong investment gains, Dana-Farber ended 2017 with net income of $21.2 million, compared to $36.8 million in 2016.
More articles on healthcare finance:
Miami hospital files for bankruptcy: 4 things to know
Moody's: Nursing shortage will pressure hospital margins for years
Wisconsin hospital at risk of losing Medicare contract over injuries to babies